Citadel Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,406
| Closed | -$352K | – | 7238 |
|
|
2022
Q2 | $352K | Sell |
6,406
-461,403
| -99% | -$25.4M | ﹤0.01% | 4478 |
|
|
2022
Q1 | $15M | Buy |
+467,809
| New | +$15M | ﹤0.01% | 1116 |
|
|
2020
Q1 | – | Sell |
-2,690
| Closed | -$37K | – | 5505 |
|
|
2019
Q4 | $37K | Sell |
2,690
-30,778
| -92% | -$423K | ﹤0.01% | 4430 |
|
|
2019
Q3 | $523K | Hold |
33,468
| – | – | ﹤0.01% | 3434 |
|
|
2019
Q2 | $750K | Sell |
33,468
-1
| -0% | -$22 | ﹤0.01% | 3210 |
|
|
2019
Q1 | $2.29M | Sell |
33,469
-12,333
| -27% | -$843K | ﹤0.01% | 2205 |
|
|
2018
Q4 | $2.42M | Buy |
45,802
+1
| +0% | +$53 | ﹤0.01% | 2046 |
|
|
2018
Q3 | $3.11M | Buy |
45,801
+13,715
| +43% | +$932K | ﹤0.01% | 1866 |
|
|
2018
Q2 | $3.8M | Buy |
+32,086
| New | +$3.8M | ﹤0.01% | 1619 |
|
|
2017
Q3 | – | Sell |
-275
| Closed | -$13K | – | 4272 |
|
|
2017
Q2 | $13K | Buy |
+275
| New | +$13K | ﹤0.01% | 3570 |
|
|
2016
Q1 | – | Sell |
-607
| Closed | -$365K | – | 4151 |
|
|
2015
Q4 | $365K | Buy |
607
+273
| +82% | +$164K | ﹤0.01% | 2603 |
|
|
2015
Q3 | $274K | Buy |
+334
| New | +$274K | ﹤0.01% | 2995 |
|